| 1 |
Davidson J, Wilkinson A, Dantal J, et al. New-onset diabetes after transplantation: 2003 International Consensus Guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003[J]. Transplantation, 2003, 75(10 Suppl):SS3-S24.
|
| 2 |
中华医学会器官移植学分会. 中国移植后糖尿病诊疗技术规范(2019版)[J]. 器官移植，2019, 10(1): 1-9.
|
| 3 |
Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions[J]. Am J Transplant, 2014, 14(9): 1992-2000.
|
| 4 |
American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl 1): S73-S85.
|
| 5 |
Woodward RS, Schnitzler MA, Baty J, et al. Incidence and cost of new onset diabetes mellitus among U．S. wait-listed and transplanted renal allograft recipients[J]. Am J Transplant, 2003, 3(5): 590-598.
|
| 6 |
Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus[J]. Am J Transplant, 2007, 7(6): 1506-1514.
|
| 7 |
Peracha J, Nath J, Ready A, et al. Risk of post-transplantation diabetes mellitus is greater in South Asian versus Caucasian kidney allograft recipients[J]. Transpl Int, 2016, 29(6): 727-739.
|
| 8 |
Dienemann T, Fujii N, Li Y, et al. Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study[J]. Transpl Int, 2016, 29(9): 1017-1028.
|
| 9 |
Shivaswamy V, Boerner B, Larsen J, et al. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes[J]. Endocr Rev, 2016, 37(1): 37-61.
|
| 10 |
Yu H, Kim H, Baek CH, et al. Risk factors for new-onset diabetes mellitus after living donor kidney transplantation in Korea-a retrospective single center study[J]. BMC Nephrol, 2016, 17(1):106.
|
| 11 |
Shah T, Kasravi A, Huang E, et al. Risk factors for development of new-onset diabetes mellitus after kidney transplantation[J]. Transplantation, 2006, 82(12): 1673-1676.
|
| 12 |
Gürsoy M, Güvener N, Köksal R, et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients[J]. Transplant Proc, 2000, 32(3): 561-562.
|
| 13 |
Chakkera HA, Hanson RL, Raza SM, et al. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation[J]. Transplant Proc, 2009, 41(10): 4172-4177
|
| 14 |
Bayer ND, Cochetti PT, Anil Kumar MS, et al. Association of metabolic syndrome with development of new-onset diabetes after transplantation[J]. Transplantation, 2010, 90(8): 861-866.
|
| 15 |
Hap K, Madziarska K, Zmonarski S, et al. Pretransplantation oral glucose tolerance test can prevent posttransplant diabetes mellitus after renal transplantation: preliminary study[J]. Transplant Proc, 2018, 50(6):1776-1780.
|
| 16 |
Han E, Kim MS, Kim YS, et al. Risk assessment and management of post-transplant diabetes mellitus[J]. Metabolism, 2016, 65(10): 1559-1569.
|
| 17 |
Vatankhah Yazdi K, Kalantar SM, Houshmand M, et al. SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are associated with type 2 diabetes mellitus in iranian patients[J]. Diabetes Metab Syndr Obes, 2020, 13: 897-906.
|
| 18 |
Voight BF, Scott LJ, Steinthorsdottir V, et al. Type 2 diabetes susceptibility loci identified through large-scale association analysis[J]. Nat Genet, 2010, 42(7): 579-589.
|
| 19 |
Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes[J]. J Clin Invest, 2007, 117(8): 2155-2163.
|
| 20 |
Laurenti MC, Dalla Man C, Varghese RT, et al. Diabetes-associated genetic variation in TCF7L2 alters pulsatile insulin secretion in humans[J]. JCI Insight, 2020, 5(7): 136136.
|
| 21 |
Ye Y, Barghouth M, Luan C, et al. The TCF7L2-dependent high-voltage activated calcium channel subunit α2δ-1 controls calcium signaling in rodent pancreatic beta-cells[J]. Mol Cell Endocrinol, 2020, 502: 110673.
|
| 22 |
Ghisdal L, Baron C, Le Meur Y, et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation[J]. J Am Soc Nephrol, 2009, 20(11): 2459-2467.
|
| 23 |
Kang ES, Kim MS, Kim CH, et al. Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea[J]. Transplantation, 2009, 88(5): 693-698.
|
| 24 |
Lv C, Chen M, Xu M, et al. Influencing factors of new-onset diabetes after a renal transplant and their effects on complications and survival rate[J]. PLoS One, 2014, 9(6): e99406.
|
| 25 |
Van Laecke S, Desideri F, Geerts A, et al. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation[J]. Liver Transpl, 2010, 16(11):1278-1287.
|
| 26 |
Haller MC, Royuela A, Nagler EV, et al. Steroid avoidance or withdrawal for kidney transplant recipients[J]. Cochrane Database Syst Rev, 2016, (8): CD005632.
|
| 27 |
Mourad G, Glyda M, Albano L, et al. Incidence of posttransplantation diabetes mellitus in de novo kidney transplant recipients receiving prolonged-release tacrolimus-based immunosuppression with 2 different corticosteroid minimization strategies: advance, a randomized controlled trial[J]. Transplantation, 2017, 101(8):1924-1934.
|
| 28 |
Song JL, Li M, Yan LN, et al. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation[J]. Int J Surg, 2018, 51: 17-23.
|
| 29 |
Wissing KM, Abramowicz D, Weekers L, et al. Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation[J]. Am J Transplant, 2018, 18(7): 1726-1734.
|
| 30 |
Garnier AS, Duveau A, Planchais M, et al. Serum magnesium after kidney transplantation: a systematic review[J]. Nutrients, 2018, 10(6): E729.
|
| 31 |
Flechner SM, Glyda M, Cockfield S, et al. The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients[J]. Am J Transplant, 2011, 11(8): 1633-1644.
|
| 32 |
Gatault P, Bertrand D, Büchler M, et al. Eight-year results of the spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation[J]. Transpl Int, 2016, 29(1): 41-50.
|
| 33 |
Bergrem HA, Valderhaug TG, Hartmann A, et al. Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy[J]. Clin J Am Soc Nephrol, 2010, 5(4): 616-622.
|
| 34 |
American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2010, 33(Suppl 1):S62-S69.
|
| 35 |
Pimentel AL, Cavagnolli G, Camargo JL, et al. Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis[J]. Nephrol Dial Transplant, 2017, 32(3): 565-572.
|
| 36 |
Sharif A, Hecking M, de Vries AP, et al. Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions[J]. Am J Transplant, 2014, 14(9): 1992-2000.
|
| 37 |
Valderhaug TG, Jenssen T, Hartmann A, et al. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation[J]. Transplantation, 2009, 88(3): 429-434.
|
| 38 |
Boerner BP, Shivaswamy V, Wolatz E, et al. Post-transplant diabetes: diagnosis and management[J]. Minerva Endocrinol, 2018, 43(2): 198-211.
|
| 39 |
Md Dom ZI, Coller JK, Carroll RP, et al. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients[J]. Br J Clin Pharmacol, 2018, 84(10): 2433-2442.
|
| 40 |
Wilkinson A, Davidson J, Dotta F, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation[J]. Clin Transplant, 2005, 19(3): 291-298.
|
| 41 |
Haidinger M, Antlanger M, Kopecky C, et al. Post-transplantation diabetes mellitus: evaluation of treatment strategies[J]. Clin Transplant, 2015, 29(5):415-424.
|
| 42 |
Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention[J]. Acta Diabetologica, 2018, 55(8): 763-779.
|